Since the NRF2- antioxidant response was shown to be important for tumor cells2,3, our goal was to examine its role in the context of the PERK-NRF2-HIF-axis to understand the underlying pathway interactions and to evaluate its benefit as a cancer target. This evidence concerns the gene EIF2AK3 and cancer.